Gasdermin E–mediated target cell pyroptosis by CAR T cells triggers cytokine release syndrome
The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
GSDME-mediated target cell pyroptosis by CAR T cells activates macrophages to release proinflammatory cytokines for CRS.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Treatment for CRS and associated neurotoxicity primarily targets IL-6, likely arising from monocytes or activated endothelium [1, 6, 11–17].”
From Immune reconstitution and clinical recovery following anti-CD28 antibody (TGN1412)-induced cytokine storm (2021) · cites this paper as [14]
In the citing paper
“Tumor lysis most likely also contributes to the cytokine storm through the induction of pyroptosis in target cells.55”
From Cytokine storm (2020) · cites this paper as [55]
Citations
Cites
Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death
Shi, J., Zhao, Y., Wang, K., Shi, X., Wang, Y., Huang, H., Zhuang, Y., Cai, T., Wang, F., & Shao, F. (2015) · Nature · doi:10.1038/nature15514 · Cited by 6,659
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
Neelapu, S. S., Locke, F. L., Bartlett, N. L., Lekakis, L. J., Miklos, D. B., Jacobson, C. A., Braunschweig, I., Oluwole, O. O., Siddiqi, T., Lin, Y., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1707447 · Cited by 6,030
Tisagenlecleucel in children and young adults with B-cell lymphoblastic leukemia
Maude, S. L., Laetsch, T. W., Buechner, J., Rives, S., Boyer, M., Bittencourt, H., Bader, P., Verneris, M. R., Stefanski, H. E., Myers, G. D., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1709866 · Cited by 5,735
Self-citationChimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
Maude, S. L., Frey, N., Shaw, P. A., Aplenc, R., Barrett, D. M., Bunin, N. J., Chew, A., Gonzalez, V. E., Zheng, Z., Lacey, S. F., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1407222 · Cited by 5,413
Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin
Wang, Y., Gao, W., Shi, X., Ding, J., Liu, W., He, H., Wang, K., & Shao, F. (2017) · Nature · doi:10.1038/nature22393 · Cited by 3,199
U.S. Department of Health and Human Services
(2006) · Encyclopedia of Sexual Behavior and the Law · doi:10.4135/9781452240107.n226 · Cited by 3,170
Pyroptosis: Gasdermin-Mediated Programmed Necrotic Cell Death
Shi, J., Gao, W., & Shao, F. (2017) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2016.10.004 · Cited by 3,088
Lee, D. W., Kochenderfer, J. N., Stetler-Stevenson, M., Cui, Y. K., Delbrook, C., Feldman, S. A., Fry, T. J., Orentas, R., Sabatino, M., Shah, N. N., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61403-3 · Cited by 2,898
Pore-forming activity and structural autoinhibition of the gasdermin family
Ding, J., Wang, K., Liu, W., She, Y., Sun, Q., Shi, J., Sun, H., Wang, D.-C., & Shao, F. (2016) · Nature · doi:10.1038/nature18590 · Cited by 2,771
Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia
Park, J. H., Rivière, I., Gonen, M., Wang, X., Sénéchal, B., Curran, K. J., Sauter, C., Wang, Y., Santomasso, B., Mead, E., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1709919 · Cited by 2,688
Cited by
Fajgenbaum, D. C., & June, C. H. (2020) · New England Journal of Medicine · doi:10.1056/nejmra2026131 · Cited by 3,196
Inflammation and tumor progression: signaling pathways and targeted intervention
Zhao, H., Wu, L., Yan, G., Chen, Y., Zhou, M., Wu, Y., & Li, Y. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00658-5 · Cited by 2,792
Pyroptosis: Mechanisms and Diseases
Yu, P., Zhang, X., Liu, N., Tang, L., Peng, C., & Chen, X. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00507-5 · Cited by 2,353
Self-citationCytokine release syndrome and associated neurotoxicity in cancer immunotherapy
Morris, E. C., Neelapu, S. S., Giavridis, T., & Sadelain, M. (2022) · Nature Reviews Immunology · doi:10.1038/s41577-021-00547-6 · Cited by 1,104
Autophagy, ferroptosis, pyroptosis, and necroptosis in tumor immunotherapy
Gao, W., Wang, X., Zhou, Y., Wang, X., & Yu, Y. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01046-3 · Cited by 1,042
“Nevertheless, pyroptosis can be triggered again in macrophages by pyroptosis releasing factors from tumor cells, leading to the release of cytokines such as IL-6 and IL-1β, which in turn triggers cytokine release syndrome (CRS).(324)”
BackgroundSelf-citationNewton, K., Strasser, A., Kayagaki, N., & Dixit, V. M. (2024) · Cell · doi:10.1016/j.cell.2023.11.044 · Cited by 990
Emerging connectivity of programmed cell death pathways and its physiological implications
Bedoui, S., Herold, M. J., & Strasser, A. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-0270-8 · Cited by 979
Tong, X., Tang, R., Xiao, M., Xu, J., Wang, W., Zhang, B., Liu, J., Yu, X., & Shi, S. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01392-3 · Cited by 883
“In detail, IL-1β and IL-18 are released through the first activated Gzm B/caspase-3/GSDME pathway in target tumor cells, which later amplifies the inflammatory response by activating the caspase-1/GSDMD axis in MΦs [343].”
BackgroundRegulated cell death (RCD) in cancer: key pathways and targeted therapies
Peng, F., Liao, M., Qin, R., Zhu, S., Peng, C., Fu, L., Chen, Y., & Han, B. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01110-y · Cited by 832
“Tumor-infiltrating immune cells can induce pyroptosis of tumor cells.(354) Chimeric antigen receptor gene-modified T (car-t) cells can induce GSDMEdependent pyroptosis in leukemia cells, and its mechanism involves the cleavage of activated GSDME in leukemia cells by granzyme B released by car-t cells.”
BackgroundChannelling inflammation: gasdermins in physiology and disease
Liu, X., Xia, S., Zhang, Z., Wu, H., & Lieberman, J. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00154-z · Cited by 751
Self-citationRole of pyroptosis in inflammation and cancer
Wei, X., Xie, F., Zhou, X., Wu, Y., Yan, H., Liu, T., Huang, J., Wang, F., Zhou, F., & Zhang, L. (2022) · Cellular & Molecular Immunology · doi:10.1038/s41423-022-00905-x · Cited by 699
“Furthermore, the concentration of granzyme B and perforin triggered by CAR-T therapy rather than existing CD8 T cells more effectively induces the pyroptosis of cancer cells [243].”
BackgroundThe caspase-3/GSDME signal pathway as a switch between apoptosis and pyroptosis in cancer
Jiang, M., Qi, L., Li, L., & Li, Y. (2020) · Cell Death Discovery · doi:10.1038/s41420-020-00349-0 · Cited by 686
Navigating CAR-T cells through the solid-tumour microenvironment
Hou, A. J., Chen, L. C., & Chen, Y. Y. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00189-2 · Cited by 551
Hsu, S.-K., Li, C.-Y., Lin, I.-L., Syue, W.-J., Chen, Y.-F., Cheng, K.-C., Teng, Y.-N., Lin, Y.-H., Yen, C.-H., & Chiu, C.-C. (2021) · Theranostics · doi:10.7150/thno.62521 · Cited by 484
“In addition, perforin secreted from CAR-T cells leads to granzyme B entry into tumor cells and caspase-3 activation, which triggers the cleavage of GSDME and pyroptosis [126] (Figure 4B).”
BackgroundPyroptosis: a new paradigm of cell death for fighting against cancer
Tan, Y., Chen, Q., Li, X., Zeng, Z., Xiong, W., Li, G., Li, X., Yang, J., Xiang, B., & Yi, M. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-01959-x · Cited by 467
“CAR T cells also induces target cell pyroptosis through release of granzyme B, activating caspase 3 and then resulting in cleavage of GSDME in B leukemic and other target cells [45].”
BackgroundThe ‘cytokine storm’: molecular mechanisms and therapeutic prospects
Karki, R., & Kanneganti, T.-D. (2021) · Trends in Immunology · doi:10.1016/j.it.2021.06.001 · Cited by 438
“Subsequent inflammatory cell death and tumor lysis induce aCS through the release of inflammatory cytokines [62].”
BackgroundCAR-T Cell Therapy in Hematological Malignancies: Current Opportunities and Challenges
Zhang, X., Zhu, L., Zhang, H., Chen, S., & Xiao, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.927153 · Cited by 396
Self-citationPyroptosis in health and disease: mechanisms, regulation and clinical perspective
Liu, Y., Pan, R., Ouyang, Y., Gu, W., Xiao, T., Yang, H., Tang, L., Wang, H., Xiang, B., & Chen, P. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01958-2 · Cited by 337
“37 Chemotherapy drugs also increase the expression of caspase-3 in GSDME cells, transform apoptosis into pyroptosis, and enhance anti-tumor immunity.”
BackgroundSelf-citationPyroptosis, metabolism, and tumor immune microenvironment
Du, T., Gao, J., Li, P., Wang, Y., Qi, Q., Liu, X., Li, J., Wang, C., & Du, L. (2021) · Clinical and Translational Medicine · doi:10.1002/ctm2.492 · Cited by 324
Programmed Cell Death Tunes Tumor Immunity
Liu, J., Hong, M., Li, Y., Chen, D., Wu, Y., & Hu, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.847345 · Cited by 316
Self-citationPyroptosis at the forefront of anticancer immunity
Loveless, R., Bloomquist, R., & Teng, Y. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-02065-8 · Cited by 316
“In large, these findings foreshadowed those seen in a leukemia CAR-T cell-induced cytokine release syndrome (CRS) mouse model (using Raji or NALM-6 cells in severe combined immunodeficient beige mice), which indicated that CAR-T cell therapy elicited CRS through GSDME-facilitated pyroptosis.”
BackgroundResultInfluentialXiao, X., Huang, S., Chen, S., Wang, Y., Sun, Q., Xu, X., & Li, Y. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-02148-6 · Cited by 310
“MAPKs and IKK regulate the release of a wide range of cytokines, including IL-6, via transcription factors activator protein 1 (AP-1) and nuclear factor κB (NF-κB) [9, 22].”
BackgroundInfluentialNLRP3 inflammasome activation triggers gasdermin D–independent inflammation
Wang, C., Yang, T., Xiao, J., Xu, C., Alippe, Y., Sun, K., Kanneganti, T.-D., Monahan, J. B., Abu-Amer, Y., Lieberman, J., et al. (2021) · Science Immunology · doi:10.1126/sciimmunol.abj3859 · Cited by 307
“GSDME is also a substrate of granzyme B ( 23 , 29 ).”
BackgroundMolecular mechanisms and functions of pyroptosis in inflammation and antitumor immunity
Hou, J., Hsu, J.-M., & Hung, M.-C. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.09.003 · Cited by 301
GSDME-mediated pyroptosis promotes the progression and associated inflammation of atherosclerosis
Wei, Y., Lan, B., Zheng, T., Yang, L., Zhang, X., Cheng, L., Tuerhongjiang, G., Yuan, Z., & Wu, Y. (2023) · Nature Communications · doi:10.1038/s41467-023-36614-w · Cited by 275
Self-citationSwitching from Apoptosis to Pyroptosis: Gasdermin-Elicited Inflammation and Antitumor Immunity
Tsuchiya, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22010426 · Cited by 255
Arcangeli, S., Bove, C., Mezzanotte, C., Camisa, B., Falcone, L., Manfredi, F., Bezzecchi, E., El Khoury, R., Norata, R., Sanvito, F., et al. (2022) · Journal of Clinical Investigation · doi:10.1172/jci150807 · Cited by 251
“Inflammasome activation in myeloid cells has recently been implicated in the development of CRS, as a consequence of tumor cell pyroptosis induced by CAR T cells (43).”
BackgroundNiu, X., Chen, L., Li, Y., Hu, Z., & He, F. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.03.009 · Cited by 245
Zhang, L., Song, A., Yang, Q.-C., Li, S.-J., Wang, S., Wan, S.-C., Sun, J., Kwok, R. T. K., Lam, J. W. Y., Deng, H., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-41121-z · Cited by 195
Gasdermins and pyroptosis in the kidney
Elias, E. E., Lyons, B., & Muruve, D. A. (2023) · Nature Reviews Nephrology · doi:10.1038/s41581-022-00662-0 · Cited by 193
Shao, W., Yang, Z., Fu, Y., Zheng, L., Liu, F., Chai, L., & Jia, J. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.676485 · Cited by 190
Mechanistic insights into gasdermin-mediated pyroptosis
Bai, Y., Pan, Y., & Liu, X. (2025) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-025-00837-0 · Cited by 174
“…to many human diseases that are not adequately treated with current therapies, including sepsis, cytokine release syndrome (speculated to be at the root of severe COVID-19), atherosclerosis, type II diabetes, systemic autoimmune diseases and rare monogenic autoinflammatory diseases 30,39–44 .”
CARD8 inflammasome activation triggers pyroptosis in human T cells
Linder, A., Bauernfried, S., Cheng, Y., Albanese, M., Jung, C., Keppler, O. T., & Hornung, V. (2020) · The EMBO Journal · doi:10.15252/embj.2020105071 · Cited by 178
“Despite the fact that IL-1 b is neither present in GSDME-expressing cells nor matured by caspase-3, GSDME-depen-dent pyroptosis downstream of caspase-3 turned out to be inflammatory (Wang et al , 2017; Liu et al , 2020).”
Cell biology of inflammasome activation
Pandey, A., Shen, C., Feng, S., & Man, S. M. (2021) · Trends in Cell Biology · doi:10.1016/j.tcb.2021.06.010 · Cited by 181
Cell death regulation: A new way for natural products to treat osteoporosis
Li, Z., Li, D., Chen, R., Gao, S., Xu, Z., & Li, N. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2022.106635 · Cited by 177
A bacterial phospholipid phosphatase inhibits host pyroptosis by hijacking ubiquitin
Chai, Q., Yu, S., Zhong, Y., Lu, Z., Qiu, C., Yu, Y., Zhang, X., Zhang, Y., Lei, Z., Qiang, L., et al. (2022) · Science · doi:10.1126/science.abq0132 · Cited by 169
Self-citationJin, J., Yuan, P., Yu, W., Lin, J., Xu, A., Xu, X., Lou, J., Yu, T., Qian, C., Liu, B., et al. (2022) · ACS Nano · doi:10.1021/acsnano.2c00192 · Cited by 167
Signaling from T cell receptors (TCRs) and chimeric antigen receptors (CARs) on T cells
Wu, L., Wei, Q., Brzostek, J., & Gascoigne, N. R. J. (2020) · Cellular and Molecular Immunology · doi:10.1038/s41423-020-0470-3 · Cited by 173
Pyroptosis and Its Role in Autoimmune Disease: A Potential Therapeutic Target
You, R., He, X., Zeng, Z., Zhan, Y., Xiao, Y., & Xiao, R. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.841732 · Cited by 159
Coral gasdermin triggers pyroptosis
Jiang, S., Zhou, Z., Sun, Y., Zhang, T., & Sun, L. (2020) · Science Immunology · doi:10.1126/sciimmunol.abd2591 · Cited by 138
“Unlike mammalian GSDME, teleost GSDME is cleaved predominately by CASP1 to generate the pyroptosis-inducing NT domain (22, 23).”
BackgroundSelf-citationGasdermin E permits interleukin-1 beta release in distinct sublytic and pyroptotic phases
Zhou, B., & Abbott, D. W. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.108998 · Cited by 138
“…studied context of GSDME in cancer cells as an apoptosis-to-pyroptosis converter (Croes et al., 2019; Ding et al., 2020; Liang et al., 2020; Liu et al., 2020; Wang et al., 2017; Yu et al., 2019), we specifically establish a causal link between GSDME cleavage and mature IL-1 β release into…”
The Antisocial Network: Cross Talk Between Cell Death Programs in Host Defense
Snyder, A. G., & Oberst, A. (2021) · Annual Review of Immunology · doi:10.1146/annurev-immunol-112019-072301 · Cited by 131
Emerging mechanisms of pyroptosis and its therapeutic strategy in cancer
Lu, L., Zhang, Y., Tan, X., Merkher, Y., Leonov, S. V., Zhu, L., Deng, Y., zhang, H., Zhu, D., Tan, Y., et al. (2022) · Cell Death Discovery · doi:10.1038/s41420-022-01101-6 · Cited by 143
“Furthermore, the quantity of perforin/granzyme B in CAR T cells but not existing CD8 T cells induces GSDME-mediated target cell pyroptosis [102].”
BackgroundInfluentialSelf-citationRamírez-Labrada, A., Pesini, C., Santiago, L., Hidalgo, S., Calvo-Pérez, A., Oñate, C., Andrés-Tovar, A., Garzón-Tituaña, M., Uranga-Murillo, I., Arias, M. A., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.896228 · Cited by 160
Control of Cell Death in Health and Disease
Kayagaki, N., Webster, J. D., & Newton, K. (2023) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-051022-014433 · Cited by 131
Hu, Y., Liu, Y., Zong, L., Zhang, W., Liu, R., Xing, Q., Liu, Z., Yan, Q., Li, W., Lei, H., et al. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-06382-y · Cited by 146
“Recent research indicates that CAR-T cells could activate the caspase-3/GSDME signaling pathway in B leukemia cells by releasing signi fi cant amounts of perforin and GzmB, which induce pyroptosis and enhance anti-tumor immunity [183].”
BackgroundSelf-citationLi, L., Wang, S., & Zhou, W. (2022) · Cancers · doi:10.3390/cancers15010026 · Cited by 131
“At the same time, DMAPs, such as adenosine triphosphate (ATP) and HMGB1, are released, which stimulate macrophages to release proinflammatory factors and cause a severe inflammatory factor storm [81].”
BackgroundBreast cancer-on-chip for patient-specific efficacy and safety testing of CAR-T cells
Maulana, T. I., Teufel, C., Cipriano, M., Roosz, J., Lazarevski, L., van den Hil, F. E., Scheller, L., Orlova, V. V., Koch, A., Hudecek, M., et al. (2024) · Cell stem cell · doi:10.1016/j.stem.2024.04.018 · Cited by 134
Lighting a Fire: Can We Harness Pyroptosis to Ignite Antitumor Immunity?
Zhang, Z., Zhang, Y., & Lieberman, J. (2021) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-20-0525 · Cited by 125
“In this study (32), CRS in mice was blocked by knocking out GSDME in the tumor.”
BackgroundSelf-citationGasdermin D pores are dynamically regulated by local phosphoinositide circuitry
Santa‐Cruz, A., Schnur, K. P., Malik, A. B., & Mo, G. C. H. (2022) · Nature Communications · doi:10.1038/s41467-021-27692-9 · Cited by 118
Wang, H., Wang, T., Yan, S., Tang, J., Zhang, Y., Wang, L., Xu, H., & Tu, C. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02183-9 · Cited by 131
“This in turn cleaves GSDME, leading to extensive pyroptosis [35, 88].”
InfluentialSelf-citationInduction of Pyroptosis: A Promising Strategy for Cancer Treatment
Wang, L., Qin, X., Liang, J., & Ge, P. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.635774 · Cited by 109
Lu, C., Guo, C., Chen, H., Zhang, H., Zhi, L., Lv, T., Li, M., Niu, Z., Lu, P., & Zhu, W. (2020) · Molecular Immunology · doi:10.1016/j.molimm.2020.04.016 · Cited by 103
A Dual‐Locked Tandem Fluorescent Probe for Imaging of Pyroptosis in Cancer Chemo‐Immunotherapy
Wang, X., He, S., Cheng, P., & Pu, K. (2022) · Advanced Materials · doi:10.1002/adma.202206510 · Cited by 101
GSDME and its role in cancer: From behind the scenes to the front of the stage
Schutter, E. D., Croes, L., Ibrahim, J., Pauwels, P., de Beeck, K. O., Vandenabeele, P., & Camp, G. V. (2020) · International Journal of Cancer · doi:10.1002/ijc.33390 · Cited by 108
“cytokine release syndrome eliciting undesirable side effects in patients.(81) Overall, more fundamental research on the biology of GSDME is required to unravel its full clinical potential.”
BackgroundJi, F., Zhang, F., Zhang, M., Long, K., Xia, M., Lu, F., Li, E., Chen, J., Li, J., Chen, Z., et al. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-021-01168-1 · Cited by 101
Role of pyroptosis in the pathogenesis of various neurological diseases
Oladapo, A., Jackson, T., Menolascino, J., & Periyasamy, P. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.02.001 · Cited by 103
Escaping Death: How Cancer Cells and Infected Cells Resist Cell-Mediated Cytotoxicity
Tuomela, K., Ambrose, A. R., & Davis, D. M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.867098 · Cited by 111
“Recently, granzyme B was also found to cleave and activate the pore-forming protein gasdermin E, leading to an alternate form of cell death, pyroptosis, through the formation of gasdermin pores in the cell membrane (48, 49).”
BackgroundTargeting pyroptosis for cancer immunotherapy: mechanistic insights and clinical perspectives
Huang, C. L., Li, J., Wu, R., Li, Y., & Zhang, C. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02344-4 · Cited by 125
“Initially, DAMPs released during pyroptosis stimulate dendritic cell maturation [74].”
InfluentialLi, X., Shao, M., Zeng, X., Qian, P., & Huang, H. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00764-4 · Cited by 99
“GSDME further leads to activation of caspase 1 and GSDMD in macrophages, which is critical for triggering CRS.(115)”
BackgroundPyroptosis and degenerative diseases of the elderly
Zhou, J., Qiu, J., Song, Y., Liang, T., Liu, S., Ren, C., Song, X., Cui, L., & Sun, Y. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-05634-1 · Cited by 98
Zhang, Y., Fang, C., Zhang, W., & Zhang, K. (2022) · Matter · doi:10.1016/j.matt.2022.08.026 · Cited by 89
Self-citationBefriending the Hostile Tumor Microenvironment in CAR T-Cell Therapy
Lindo, L., Wilkinson, L., & Hay, K. A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.618387 · Cited by 99
Sun, S.-J., Jiao, X., Chen, Z., Cao, Q., Zhu, J., Shen, Q., Liu, Y. F., Zhang, Z., Xu, F., Shi, Y. L., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-50996-5 · Cited by 99
“T lymphocytes recruitment into tumour 17,18 .”
Self-citationPyroptosis in Cancer: Friend or Foe?
Lu, X., Guo, T., & Zhang, X. (2021) · Cancers · doi:10.3390/cancers13143620 · Cited by 92
Self-citationProgrammed Cell Death in Asthma: Apoptosis, Autophagy, Pyroptosis, Ferroptosis, and Necroptosis
Liu, L., Zhou, L., Wang, L., Zheng, P., Zhang, F., Mao, Z., Zhang, H., & Liu, H. (2023) · Journal of Inflammation Research · doi:10.2147/jir.s417801 · Cited by 84
“In recent years, studies have discovered that granzyme A and granzyme B can also hydrolyze GSDMB to create cytoplasmic membrane pores, thus proposing a granzymemediated pathway of pyroptosis.(147,148)”
Significance of Programmed Cell Death Pathways in Neurodegenerative Diseases
Guo, D., Liu, Z., Zhou, J., Ke, C., & Li, D. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25189947 · Cited by 88
“Moreover, granzyme A from cytotoxic lymphocytes and granzyme B from natural killer (NK) cells can cleave GSDMB and GSDME, respectively, contributing to the release of their N-terminus and the activation of pyroptosis [77,78].”
BackgroundZheng, N., Fang, J., Xue, G., Wang, Z., Li, X., Zhou, M., Jin, G., Rahman, M. M., McFadden, G., & Lu, Y. (2022) · Cancer Cell · doi:10.1016/j.ccell.2022.08.001 · Cited by 88
Self-citationUSP48 Stabilizes Gasdermin E to Promote Pyroptosis in Cancer
Ren, Y., Feng, M., Hao, X., Liu, X., Li, J., Li, P., Gao, J., Qi, Q., Du, L., Wang, C., et al. (2023) · Cancer Research · doi:10.1158/0008-5472.can-22-1812 · Cited by 85
Exploring CAR-T Cell Therapy Side Effects: Mechanisms and Management Strategies
Zhang, Y., Qin, D., Shou, A., Liu, Y., Wang, Y., & Zhou, L. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12196124 · Cited by 85
Self-citationMo, F., Duan, S., Jiang, X., Yang, X., Hou, X., Shi, W., Jumbo, J. C. C., Liu, A., Yin, S., Wang, W., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00462-1 · Cited by 83
Molecular mechanisms and functions of pyroptosis in sepsis and sepsis-associated organ dysfunction
Wen, R., Liu, Y., Tong, X.-X., Zhang, T., & Yang, N. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.962139 · Cited by 84
Self-citationRegulation of Lytic and Non-Lytic Functions of Gasdermin Pores
Rühl, S., & Broz, P. (2022) · Journal of Molecular Biology · doi:10.1016/j.jmb.2021.167246 · Cited by 74
Gasdermin E dictates inflammatory responses by controlling the mode of neutrophil death
Ma, F., Ghimire, L., Ren, Q., Fan, Y., Chen, T., Balasubramanian, A., Hsu, A. Y.-H., Liu, F., Yu, H., Xie, X., et al. (2024) · Nature Communications · doi:10.1038/s41467-023-44669-y · Cited by 89
Cao, W., Chen, G., Wu, L., Yu, K. N., Sun, M., Yang, M., Jiang, Y., Jiang, Y., Yuan, X., Peng, S., et al. (2022) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2022.07.1841 · Cited by 77
Li, X., Gong, N., Tian, F., Zhang, S., Zhang, Y., Wang, Y., Qing, G., Wang, Y., Li, F., Xu, Y., et al. (2023) · Nature Biomedical Engineering · doi:10.1038/s41551-023-01084-4 · Cited by 81
Self-citationPyroptosis: A Newly Discovered Therapeutic Target for Ischemia-Reperfusion Injury
Zheng, Y., Xu, X., Chi, F., & Cong, N. (2022) · Biomolecules · doi:10.3390/biom12111625 · Cited by 73
“A 2020 study found that CAR T cells could activate caspase-3 in target cells by releasing granzyme B (GzmB), thus activating the caspase-3/GSDME-mediated pyroptotic pathway [46].”
BackgroundThe gasdermin protein family: emerging roles in gastrointestinal health and disease
Privitera, G., Rana, N., Armuzzi, A., & Pizarro, T. T. (2023) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-023-00743-w · Cited by 75
Pyroptosis relates to tumor microenvironment remodeling and prognosis: A pan-cancer perspective
Khan, M. B., Ai, M.-L., Du, K., Song, J., Wang, B., Lin, J., Ren, A., Chen, C., Huang, Z., Qiu, W., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1062225 · Cited by 72
“Granzymes, granzyme A and B (GZMA, GZMB), are also indicated in direct cleavage of gasdermin proteins (11, 12).”
BackgroundPosttranslational and Therapeutic Control of Gasdermin-Mediated Pyroptosis and Inflammation
Fischer, F. A., Chen, K. W., & Bezbradica, J. S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.661162 · Cited by 75
Kauer, J., Hörner, S., Osburg, L., Müller, S., Märklin, M., Heitmann, J. S., Zekri, L., Rammensee, H., Salih, H. R., & Jung, G. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-000621 · Cited by 71
Li, S., Ming, Y., Xu, H., Zhang, X., Mao, T., Quan, M., Ma, J., Wang, Y., Ge, W., Wang, Y., et al. (2023) · Cancer Letters · doi:10.1016/j.canlet.2023.216206 · Cited by 71
Self-citationThe emerging role of pyroptosis in pediatric cancers: from mechanism to therapy
Wang, H., Zhou, X., Li, C., Yan, S., Feng, C., He, J., Li, Z., & Tu, C. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01365-6 · Cited by 69
Wei, Z., Gao, R., Sun, Z., Yang, W., He, Q., Wang, C., Zhang, J., Zhang, X., Guo, L., & Wang, S. (2023) · Journal of Medical Virology · doi:10.1002/jmv.28790 · Cited by 68
“Pyroptosis, an inflammatory form of PCD, is characterized by cell swelling, in which cellular contents are rapidly released and eventually result in extreme tissue damage and cytokine storm.(13,14) In several experimental studies and clinical trials, cytokine storm has been revealed to be directly associated with wide…”
BackgroundSelf-citationLv, J., Liu, Y., Mo, S., Zhou, Y., Chen, F., Cheng, F., Li, C., Saimi, D., Liu, M., Zhang, H., et al. (2022) · Nature Cell Biology · doi:10.1038/s41556-022-00857-4 · Cited by 67
Self-citationPyroptosis Provides New Strategies for the Treatment of Cancer
Jia, Y., Wang, X., Deng, Y., Li, S., Xu, X., Qin, Y., & Peng, L. J. (2023) · Journal of Cancer · doi:10.7150/jca.77965 · Cited by 69
“The formation of pores is not confined to the cell membrane, other membranes within the cell, such as mitochondrial membranes, can also form pores [42].”
BackgroundCAR-T cell therapy: Where are we now, and where are we heading?
Wang, J., & Wang, L. (2023) · Blood Science · doi:10.1097/bs9.0000000000000173 · Cited by 71
Chen, K., Shang, S., Yu, S., Cui, L., Li, S., & He, N. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.998470 · Cited by 62
Diorio, C., Shaw, P. A., Pequignot, E., Orlenko, A., Chen, F., Aplenc, R., Barrett, D. M., Bassiri, H., Behrens, E., DiNofia, A. M., et al. (2020) · Blood Advances · doi:10.1182/bloodadvances.2020002592 · Cited by 61
“This finding is congruent with previous observations made by our group and others about the fundamental role of macrophages in CRS following CAR-T cell therapy.(8,17,27) Severe CRS in some patients closely resembles hemophagocytic lymphohistiocytosis, with patients developing high fevers, hyperferritinemia, organomega…”
ResultTime to evolve: predicting engineered T cell-associated toxicity with next-generation models
Donnadieu, E., Luu, M., Alb, M., Anliker, B., Arcangeli, S., Bonini, C., Angelis, B. D., Choudhary, R., Espie, D., Galy, A. H. M., et al. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-003486 · Cited by 68
Biomaterials Elicit Pyroptosis Enhancing Cancer Immunotherapy
Zhang, M., Wang, Y., Han, L., Liu, X., Xie, Y., Xu, Z., & Sun, Z. (2023) · Advanced Functional Materials · doi:10.1002/adfm.202311362 · Cited by 64
Pyroptosis: A promising therapeutic target for noninfectious diseases
Li, T., Zheng, G., Li, B., & Tang, L. (2021) · Cell Proliferation · doi:10.1111/cpr.13137 · Cited by 63
The multifaceted roles of gasdermins in cancer biology and oncologic therapies
Sarrió, D., Martínez-Val, J., Molina-Crespo, Á., Sanchez, L. E., & Moreno‐Bueno, G. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2021.188635 · Cited by 59
Catanzaro, E., Féron, O., Skirtach, A. G., & Krysko, D. V. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.925290 · Cited by 62
Challenges of Anti-Mesothelin CAR-T-Cell Therapy
Zhai, X., Mao, L., Wu, M., Liu, J., & Yu, S. (2023) · Cancers · doi:10.3390/cancers15051357 · Cited by 60
“It has been reported [70] that CAR-T cells release granzyme B, activate caspase 3 and cleave GSDME in target tumor cells, leading to pyroptosis, thereby activating caspase 1 and GSDMD in macrophages and triggering CRS.”
BackgroundRole of pyroptosis in the pathogenesis and treatment of diseases
Jin, X., Ma, Y., Liu, D., & Huang, Y. (2023) · MedComm · doi:10.1002/mco2.249 · Cited by 66
The role of pyroptosis and gasdermin family in tumor progression and immune microenvironment
Li, M., Jiang, P., Yang, Y., Xiong, L., Wei, S., Wang, J., & Li, C. (2023) · Experimental Hematology and Oncology · doi:10.1186/s40164-023-00464-5 · Cited by 71
“However, it is important to acknowledge that the inflammatory factors induced by pyroptosis may contribute to cytokine release syndrome (CRS), a common and severe complication associated with CAR-T therapy, which limits its broader clinical application [19].”
BackgroundXiao, J., Wang, C., Yao, J.-C., Alippe, Y., Yang, T., Kress, D., Sun, K., Kostecki, K. L., Monahan, J. B., Novack, D. V., et al. (2020) · PLoS Biology · doi:10.1371/journal.pbio.3000807 · Cited by 57
Xu, X., Huang, S., Xiao, X., Sun, Q., Liang, X., Chen, S., Zhao, Z., Huo, Z., Tu, S., & Li, Y. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.569117 · Cited by 66
“A recent study proposed that CAR T-cell–induced pyroptosis of targeT-cells rather than apoptosis is a critical reason for CRS (90).”
BackgroundSelf-citationNanobodies in cell-mediated immunotherapy: On the road to fight cancer
Maali, A., Gholizadeh, M., Feghhi-Najafabadi, S., Noei, A., Seyed-Motahari, S. S., Mansoori, S., & Sharifzadeh, Z. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1012841 · Cited by 67
Metadata
- Authors
- Liu, Y., Fang, Y., Chen, X., Wang, Z., Liang, X., Zhang, T., Liu, M., Zhou, N., Lv, J., Tang, K., Xie, J., Gao, Y., Cheng, F., Zhou, Y., Zhang, Z., Hu, Y., Zhang, X., Gao, Q., Zhang, Y., & Huang, B.
- Affiliations
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- First Affiliated Hospital of Zhengzhou University (CN)
- Huazhong University of Science and Technology (CN)
- Wuhan Union Hospital (CN)
- Peking University People's Hospital (CN)
- Zhengzhou University (CN)
- Corresponding author
- Liu, Yuying
- Fang, Yiliang
- Chen, Xinfeng
- Huang, Bo
- ORCID
- Venue
- Science Immunology
- Published
- 2020-01-03
- Volume
- 5
- Issue
- 43
- ISSN
- 2470-9468 (ISSN-L)
- OpenAlex
- W2999534343
- Cited by
- 566
- References
- 45
- Citations by year
- 2026: 63 · 2025: 87 · 2024: 100 · 2023: 127 · 2022: 96 · 2021: 70 · 2020: 22
- FWCI
- 28.45
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science Immunology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (81788101, 81661128007, 81530080, 81773062)
- Topics
- Health Sciences › Medicine › Oncology › CAR-T cell therapy research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Keywords
- gasdermin E, pyroptosis, chimeric antigen receptor T cells, cytokine release syndrome, macrophage activation, inflammatory cytokines, target cell death, adoptive T cell therapy
- MeSH terms
- Pyroptosis, Cytokine Release Syndrome, Gasdermins, Animals, Female, Humans, Macrophages, T-Lymphocytes, Leukemia, B-Cell, Immunotherapy, Adoptive, Phosphate-Binding Proteins, Cell Line, Tumor, Intracellular Signaling Peptides and Proteins, Mice, Granzymes, Perforin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.